Tango Therapeutics (TNGX) Short-term Investments (2020 - 2025)

Tango Therapeutics' Short-term Investments history runs 6 years deep, the most recent figure standing at $428000.0 for Q4 2025.

• On a quarterly basis, Short-term Investments fell 99.77% year-over-year to $428000.0 in Q4 2025; TTM through Dec 2025 was $428000.0, a 99.77% decrease from a year earlier, with the FY2025 full-year figure at $428000.0, down 99.77% from the prior year.
• Short-term Investments was little changed at $428000.0 in Q4 2025 per TNGX's latest filing, from $428000.0 in the prior quarter.
• Across five years, Short-term Investments topped out at $350.0 million in Q1 2022 and bottomed at $428000.0 in Q3 2025.
• The 5-year median for Short-term Investments is $173.3 million (2024), against an average of $153.1 million.
• Across the five-year window, Short-term Investments soared 53047.62% in 2023 and slumped 99.82% in 2025, its largest moves.
• Year by year, Short-term Investments stood at $567000.0 in 2021, then changed by 0.0% to $567000.0 in 2022, then soared by 50.97% to $856000.0 in 2023, then soared by 21907.83% to $188.4 million in 2024, then sank by 99.77% to $428000.0 in 2025.
• Per Business Quant, the three latest TNGX Short-term Investments figures stand at $428000.0 (Q4 2025), $428000.0 (Q3 2025), and $141.5 million (Q2 2025).